Literature DB >> 15804531

Molecular basis of the low activity of antitumor anthracenediones, mitoxantrone and ametantrone, in oxygen radical generation catalyzed by NADH dehydrogenase. Enzymatic and molecular modelling studies.

Jolanta Tarasiuk1, Jan Mazerski, Katarzyna Tkaczyk-Gobis, Edward Borowski.   

Abstract

Synthetic antitumor anthracenedione drugs, in contrast to anthracycline antibiotics, are ineffective in free radical formation in NADH dehydrogenase system. Our results have indicated that neither the reduction potential nor the side chain conformation and the energies of border orbitals (HOMO and LUMO) determine the ability of anthracenediones to stimulate reactive oxygen species formation in NADH dehydrogenase system. It was shown that the distribution of the molecular electrostatic potential (MEP), around the quinone system was crucial for this ability. We have found for non-stimulating anthracenediones that the clouds of positive MEP cover the quinone carbon atoms while for agents effective in stimulating reactive oxygen species formation the clouds of negative MEP cover continuously the aromatic core together with the quinone system.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15804531     DOI: 10.1016/j.ejmech.2004.10.005

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  3 in total

Review 1.  Immunogenic cell death and DAMPs in cancer therapy.

Authors:  Dmitri V Krysko; Abhishek D Garg; Agnieszka Kaczmarek; Olga Krysko; Patrizia Agostinis; Peter Vandenabeele
Journal:  Nat Rev Cancer       Date:  2012-11-15       Impact factor: 60.716

2.  Synthesis, cytotoxicity, DNA binding and apoptosis of rhein-phosphonate derivatives as antitumor agents.

Authors:  Man-Yi Ye; Gui-Yang Yao; Jing-Chen Wei; Ying-Ming Pan; Zhi-Xin Liao; Heng-Shan Wang
Journal:  Int J Mol Sci       Date:  2013-04-29       Impact factor: 5.923

Review 3.  Engineering nanomedicines through boosting immunogenic cell death for improved cancer immunotherapy.

Authors:  Jing Gao; Wei-Qi Wang; Qing Pei; Megan S Lord; Hai-Jun Yu
Journal:  Acta Pharmacol Sin       Date:  2020-04-21       Impact factor: 6.150

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.